CLINICAL_TRIALS
withdrawal
· 2021-10-07
Clinical Trial Update: Melatonin for Delirium Prophylaxis [Phase 4]
Summary
Phase 4 trial of melatonin for delirium prophylaxis has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of British Columbia | Conditions: Delirium | Phase 4 | Status: WITHDRAWN